Cargando…
Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Results From a Phase 2 Trial
BACKGROUND: Maternal immunization against group B streptococcus (GBS) could protect infants from invasive GBS disease. Additional doses in subsequent pregnancies may be needed. We evaluated the safety and immunogenicity of a second dose of an investigational trivalent CRM(197)-glycoconjugate GBS vac...
Autores principales: | Leroux-Roels, Geert, Bebia, Zourab, Maes, Cathy, Aerssens, Annelies, De Boever, Fien, Grassano, Luca, Buffi, Giada, Margarit, Immaculada, Karsten, Annette, Cho, Stephen, Slobod, Karen, Corsaro, Bartholomew, Henry, Ouzama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286364/ https://www.ncbi.nlm.nih.gov/pubmed/31394574 http://dx.doi.org/10.1093/cid/ciz737 |
Ejemplares similares
-
1110 Identification of Formulations and Vaccine Schedules of a Trivalent Group B Streptococcus Vaccine for Further Development in Non-pregnant and Pregnant Women
por: Leroux-Roels, Geert, et al.
Publicado: (2014) -
Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2023) -
Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women
por: Schwarz, Tino F, et al.
Publicado: (2021) -
Pregnancy has a minimal impact on the acute transcriptional signature to vaccination
por: Tregoning, John S., et al.
Publicado: (2020) -
Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)